![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
Title
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
Phase ![sort descending](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/arrow_down.gif)
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
Protocol IDs
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase III
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
EFC6668
XRP9881, NCT00625664
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II, Phase I
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
CCC-PHII-75
7435, NCI-7435, NCT00365157
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Randomized Phase II Study for Patients With Previously Treated Advanced Urothelial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
FER-GU-004
NCT00350025
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
MSKCC-06081
NCT00397488
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
UMCC 2005.145
NCT00393796
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Pazopanib in Treating Patients With Metastatic Urothelial Cancer
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
MCCRC-MC0553
7661, MC0553, NCT00471536
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-Naive Patients With Advanced/Metastatic Bladder Carcinoma
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
0609001823
NCT00461851
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
MDA-2005-0839
MDA-2005-0939, 2005-0839, 7341, NCT00478361
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Docetaxel With or Without Vandetanib in Treating Patients With Previously Treated Stage IV Transitional Cell Cancer
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
DFCI-06116
FHCRC-6451, UWCC-UW-6451, UWCC-07-5533-H/D, 06-116, NCT00378794
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
Phase II
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
06-006
NCT00588666
![](https://webarchive.library.unt.edu/eot2008/20081023115118im_/http://www.cancer.gov/images/spacer.gif)
|
|